copy of dr. puhalla on the value of biosimilars in oncology
Published 5 years ago • 12 plays • Length 0:10Download video MP4
Download video MP3
Similar videos
-
0:53
dr. puhalla on the value of biosimilars in oncology
-
1:44
dr. tripathy on the importance of biosimilars in oncology
-
1:48
dr. markman on the concept of biosimilars in oncology
-
0:55
dr. weise discusses the value of biosimilars in oncology
-
1:08
dr. tripathy on the progression of biosimilars in oncology
-
0:44
dr. hamilton on the impact of biosimilars in oncology
-
0:55
dr. slamon discusses the future of biosimilars in oncology
-
0:58
dr. hurvitz on the clinical use of biosimilars in oncology
-
57:41
webinar: biologics & biosimilars
-
4:12
the basics of biosimilars
-
5:20
data requirements for biosimilars
-
0:57
dr. somer on the expansion of biosimilars in oncology
-
1:30
dr. mcbride on the potential impact of bevacizumab biosimilars in oncology
-
0:42
dr. cristofanilli on the need for biosimilars in oncology
-
0:45
dr. preeshagul on education for biosimilars in oncology
-
1:08
dr. savin discusses the future of biosimilars in oncology
-
1:51
dr. pegram on future impact of biosimilars in oncology
-
1:16
dr. weise discusses the future of biosimilars in oncology
-
0:20
copy of dr. tripathy on the importance of biosimilars in oncology
-
1:05
dr. schwartzberg on increasing competition with biosimilars in oncology
-
5:56
the complexity of choosing biosimilars in oncology
-
1:08
dr. litton discusses the potential advantage of using biosimilars in oncology